January 2015

IATI Biomed May 12-14 Tel Aviv. IATI Biomed will be held May-14 in Tel Aviv. The conference is a meeting place for healthcare’s industry players from Israel and abroad. Exuberance is felt everywhere; lectures, exhibition halls and partnership meetings. International visitors come to witness the various innovations, and experience firsthand the entrepreneurial spirit so strongly exhibited within the vibrant Israeli life science community.
 
Save the date: Ctrials association, the Israeli association for advancement of the biomedical research community, will host its annual conference for research and clinical trials, on April 28 2015 at David Intercontinental hotel in Tel Aviv (Hebrew).

Bioforum published the 2015 yearly program of courses and seminars (Hebrew).
 
The new website http://medical-research.co.il/ performed annual analysis of the website data for 2014, which resulted in some surprising findings: an increase of 65% for Google searches related to "Clinical Studies" and "Medical Studies" compared to 2013. In addition, in 2014 the number of visits to the site via mobile devices increased by 25.9% over 2013. In 2014 the number of published studies which recruit patients, increased by 38% compared to 2013 (Hebrew).
 
Patient monitoring solutions company EarlySense raises $20m. EarlySense, which provides solutions for contact-free patient monitoring, announced that it has completed a $20 million financing round, led by Samsung Ventures with an investment of $10 million. Existing investors whose participation was also substantial include Pitango Venture Capital, Welch Allyn, JK&B, Proseed and Noaber.
 
Gamida Cell Gets FDA Orphan Drug Approval. Israel’s Gamida Cell, a developer of cell therapy technologies and products for transplantation and adaptive immune therapy, announced that orphan drug designation has been granted by the FDA for its investigational medicinal product NiCord. The drug is used for the treatment of acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), Hodgkin lymphoma and myelodysplastic syndrome (MDS).
 
Israel ranked 5th in Bloomberg innovation index. Israel is the world’s fifth-most innovative country, according to the 2015 Bloomberg Global innovation index. South Korea topped the list, followed by Japan, Germany and Finland ahead of Israel, while the United States was just behind it at No. 6. The index was comprised based on rankings in six subfields: Research and development, in which Israel ranked No. 2, manufacturing (21), hi-tech companies (11), post-secondary education (4), research personnel (4) and patents (31).
 
Samsung invested in 8 Israeli start-ups in 2014. Samsung has become a massive investor in Israeli start-ups over the past year. Samsung Electronics President and Chief Strategy Officer Young Sohn said that the South Korean electronics giant invested in eight Israeli companies in 2014. “We are no longer the giant that buys companies, but rather a partner. This is a change in our thinking. We invest a lot of money in start-ups around the world. Our investments have reached $1.4 billion, to date. Our investments start at $250,000, and can reach as much as $25 million.”